Screener
Bicara Therapeutics BCAX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Income tax expense | (52) | (72) |
| Net loss | $(56,211) | $(36,846) |
| Net Loss per share, basic and diluted | $(0.93) | $(0.68) |
| Weighted-average number common shares outstanding, basic and diluted | 60,717,041 | 54,456,515 |
| Other comprehensive loss: | ||
| Unrealized loss on marketable securities, net of tax | (486) | — |
| Total other comprehensive loss | (486) | — |
| Total comprehensive loss | $(56,697) | $(36,846) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Bicara Therapeutics (BCAX) reported comprehensive income (loss), net of tax, attributable to parent of -$56.7M in Q1 2026.
- How has Bicara Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Bicara Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 53.9% year-over-year, from -$36.85M to -$56.7M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- The sum of net income and other comprehensive income, representing the total change in equity from non-owner sources during a reporting period. This metric provides a comprehensive view of the company's financial health by incorporating both operational results and unrealized market gains or losses. It is essential for understanding the total economic impact on shareholder equity.
Ask your AI about Bicara Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude